海外の治験の状況「1」での検索結果
1993件の検索結果
- 進捗状況
- 試験名
- 対象疾患名
- 地域
- 登録日
Authorised
- Pembrolizumab plus epacadostat, pembrolizumab monotherapy, and the EXTREME regimen as first line treatment for R/M HNSCC (KEYNOTE-669/ECHO-304)
- Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma MedDRA version: 20.0 Level: PT Classification code 10060121 Term: Squamous cell carcinoma of head and neck System Organ Class: 10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps) ;Therapeutic area: Diseases [C] - Cancer [C04]
- Australia, Austria, Brazil, Canada, France, Germany, Hungary, Italy, Japan, Korea, Republic of, Mexico, Poland, Portugal, Spain, Taiwan, Turkey, United Kingdom, United States
- 2017-10-24
Authorised
- Pembrolizumab (MK-3475) as First-Line Therapy for Advanced Merkel Cell Carcinoma
- Unresectable Stage III and Stage IV Merkel Cell Carcinoma (MCC) MedDRA version: 20.0 Level: LLT Classification code 10064025 Term: Merkel cell carcinoma System Organ Class: 100000004864 ;Therapeutic area: Diseases [C] - Cancer [C04]
- Australia, Canada, France, Italy, New Zealand, Spain, Sweden, United States
- 2018-10-24
Authorised
- First-line chemotherapy plus pembrolizumab and olaparib for BRCA non-mutated advanced EOC
- Advanced epithelial ovarian cancer MedDRA version: 20.0 Level: PT Classification code 10033128 Term: Ovarian cancer System Organ Class: 10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps) ;Therapeutic area: Diseases [C] - Cancer [C04]
- Australia, Belgium, Brazil, Canada, Chile, Colombia, Czech Republic, France, Germany, Hungary, Ireland, Israel, Italy, Japan, Korea, Republic of, New Zealand, Poland, Russian Federation, South Africa, Spain, Taiwan, Turkey, Ukraine, United Kingdom, United States
- 2018-10-23
Authorised
- 4 - weeks, double blind, parallel, randomized study: Comparison of repetitive transcranial magnetic stimulation (rTMS) and venlafaxine (Effectin ER) in the treatment of resistant depressive disorder - D-RTMS-VEN
- Rezistentní depresivní porucha, tj. depresivní porucha, která nedostatecne odpovedela 1. lécebný pokus antidepresivem
- Czech Republic
- 2005-04-04
Authorised
- A comparison of pharmacodynamics and pharmacokinetics of Insulin Aspart and Biphasic Insulin Aspart 30, 50 og 70. A quadruple cross-over trial. - Asp-BIAsp-2005/0109
- Patients with type 1 diabetes
- Denmark
- 2008-05-20
Authorised
- Full dose S1 compared to reduced dose S-1/oxaliplatin. First-line treatment for older patients with metastic colorectal cancer.
- Treatment of older (= 70 years) patients with metastatic colorectal cancer MedDRA version: 20.0 Level: PT Classification code 10052358 Term: Colorectal cancer metastatic System Organ Class: 10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps) ;Therapeutic area: Diseases [C] - Cancer [C04]
- Denmark, Finland, Norway
- 2014-03-05
Authorised
- Mechanism of action study of anti-IL17 treatment in spondyloarthritis.
- Spondyloarthritis MedDRA version: 16.1 Level: LLT Classification code 10032155 Term: Other inflammatory spondylopathies System Organ Class: 100000004859 MedDRA version: 16.1 Level: LLT Classification code 10070759 Term: Spondylopathy System Organ Class: 100000004859 ;Therapeutic area: Diseases [C] - Musculoskeletal Diseases [C05]
- Netherlands
- 2014-01-16
Authorised
- Impact of treatment with Dapagliflozin in type 1 diabetic patients
- Type 1 diabetes MedDRA version: 18.0 Level: PT Classification code 10067584 Term: Type 1 diabetes mellitus System Organ Class: 10027433 - Metabolism and nutrition disorders ;Therapeutic area: Diseases [C] - Nutritional and Metabolic Diseases [C18]
- Spain
- 2015-07-31
Authorised
- Phase 4 Study of Brentuximab Vedotin in Patients With Relapsed or Refractory Systemic Anaplastic Large Cell Lymphoma
- Relapsed or Refractory Systemic Anaplastic Large Cell Lymphoma MedDRA version: 20.0 Level: HLT Classification code 10002235 Term: Anaplastic large cell lymphomas T- and null-cell types System Organ Class: 100000004851 ;Therapeutic area: Diseases [C] - Cancer [C04]
- Belgium, Croatia, Czech Republic, Hungary, Poland, Portugal, Romania, Spain, Turkey, United Kingdom
- 2013-04-15
Authorised
- Infliximab as first treatment instead of second line treatment in Crohns disease
- Crohn's disease;Therapeutic area: Diseases [C] - Digestive System Diseases [C06]
- Belgium, Italy, Netherlands
- 2012-07-12